SCHOTT Pharma is a global leader in providing advanced pharmaceutical packaging solutions. For over a century, the SCHOTT name has been synonymous with advanced solutions and services for the pharmaceutical and biotech industries globally. Leveraging this extensive expertise, SCHOTT Pharma provides a scientifically proven product portfolio for the safe storage and administration of injectable drugs worldwide.
Driven by a commitment to quality, innovation, and sustainability, we specialize in glass and polymer drug containment and delivery solutions. Our diverse portfolio includes prefillable syringes, cartridges, vials, and ampoules, complemented by tailored analytical, development, fill-and-finish, and regulatory services designed for pharmaceutical companies, Biotechs, and CDMOs.
Through collaborative partnerships and ongoing advancements in packaging technology, SCHOTT Pharma continuously strives to setting new standards in safely delivering medication to patients. Supported by our dedicated team of researchers and accredited analytical laboratories, we provide scientifically grounded solutions to assist pharmaceutical companies in tackling complex challenges.
At SCHOTT Pharma, we’re deeply committed to sustainability and corporate social responsibility (CSR), integrating eco-friendly practices into our products and services. We’re also dedicated to supporting your sustainability efforts throughout your supply chain. Through our services, including sustainability performance evaluations and product carbon footprint assessments, we provide streamlined solutions to meet your needs. Leveraging the EcoVadis platform, we offer quick access to standardized sustainability data. Additionally, our tailored carbon footprint assessments foster collaboration to minimize emissions in containment solutions, ensuring a path toward a net-zero future.
Whether composed of advanced polymers or glass, prefillable syringes by SCHOTT Pharma provide an optimal solution for drugs requiring a stable and secure long-term storage. These syringes also offer a safe and simple delivery method for clinicians and patients alike, allowing for easy and accurate dosing.
SCHOTT Pharma cartridges are a top choice for drug dosing, offering exceptional accuracy and compatibility with a variety of devices. Whether in emergency situations or for self-administration by diabetes patients, our cartridges provide a safe and user-friendly method for delivering drugs with precision. Robust and reliable, SCHOTT Pharma cartridges are trusted by healthcare professionals worldwide. Our cartridges are also available as RTU. Choose SCHOTT Pharma for accurate and reliable drug dosing with our high-quality cartridges.
When it comes to the safe storage of liquid drug formulations, SCHOTT Pharma vials are the optimal choice. Made of Type I Borosilicate Glass, our vials offer high chemical resistance and superior cosmetic quality, ensuring an efficient fill-and-finish process and secure container closure integrity. With accurate dimensions and a range of sizes to choose from, SCHOTT Pharma vials provide a secure and reliable storage solution for liquid drug formulations of all kinds, even as RTU. Choose SCHOTT Pharma for safe and secure storage of your liquid drug formulations with our high-quality vials.
When it comes to storing your drugs safely and reliably, choose SCHOTT Pharma's range of ampoules. Manufactured using Type I Borosilicate Glass, our ampoules offer high chemical resistance, accurate dimensions, tight cosmetic control, and drug stability from production to procedure. With a focus on quality and safety, SCHOTT Pharma's ampoules provide the optimal solution for storing and delivering drugs with confidence. Choose SCHOTT Pharma for a safe and stable storage solution for your drugs that meets the highest quality standards.
Protecting medication from undesired interactions with the surrounding environment and preserving their efficacy during shelf life is one of the most pressing challenges for the pharmaceutical industry.
The recent spike in market recalls for injectable drug products due to visible flaky particles associated with 'glass delamination' demonstrates the need to solve these problems.
Recently, the US Food and Drug Administration (FDA) addressed a warning to a US pharmaceuticals company, when third-party manufactured glass vials were found to contain glass particles upon inspection. SCHOTT Pharmaceutical Packaging Division, part of the multinational technology-based
New drugs generate new challenges in the field of pharmaceutical packaging. "Biomolecules, for instance, are being used today in over 50% of all product developments in pharmaceutical therapy," says Dr Claudia Dietrich, product manager for vials and coating at SCHOTT in St. Gallen, Switzerlan
With a new manufacturing facility for premium-quality ampoules and vials in Zavolzhe, near the Russian city of Nizhny Novgorod, the German technology company and global quality leader SCHOTT will extend its leading position in the area of high-quality pharmaceutical packaging in Russia. At the 'P
The German technology group SCHOTT and the Japanese company Naigai Glass Industry recently founded a joint venture for pharmaceutical packaging activities in Japan, which came into effect from 1 October 2010. The new company is called SCHOTT NAIGAI K.K. and is based in Osaka, Japan, where Naiga
SCHOTT Pharmaceutical Systems, one of the world's leading suppliers of glass tubing and primary packaging for the pharmaceutical industry, continues to expand its global network. The company will open up a new production plant in Russia this month and plans to further strengthen its position in J
International technology group SCHOTT today officially inaugurated a production site for primary pharmaceutical packaging located in Zavolzhe, near the Russian city of Nizhny Novgorod. The new production site will employ around 60 employees initially and will produce premium quality ampoules and
From 12-18 May, SCHOTT presented its innovative solutions in the area of parenteral packacking for the pharmaceutical industry under the motto 'Your Trusted Partner for Quality Packaging Solutions, Worldwide' at the Interpack 2011 event in Düsseldorf, Germany. On two floors and an
SCHOTT has appointed Christophe Muguet as vice-president of its global syringe business. He leads this area's business activities as part of SCHOTT Pharmaceutical Packaging from the offices in St Gallen, Switzerland.
SCHOTT Pharmaceutical Packaging has released a new, free-to-download white paper which explores ways to minimize the delamination risk of glass containers.
SCHOTT Pharmaceutical Packaging continues to experience growth in Russia and now plans to increase the production capacities at its plant in in Zavolzhe by more than 50%. The manufacturer announced this move today at the Pharmtech trade fair in Moscow.
SCHOTT Pharmaceutical Systems has unveiled plans for the significant expansion of its Hungarian site Lukácsháza, which manufactures pharmaceutical primary packaging.
SCHOTT is to launch SCHOTT Vials DC, which are pharmaceutical vials that, for the first time ever, allows for the risk of delamination to be determined based on threshold values.
With adaptiQ, SCHOTT will be unveiling a new concept of ready-to-use pharmaceutical vials that has been modified in close cooperation with filling line manufacturers to meet the process requirements of the pharmaceutical industry.
SCHOTT Pharmaceutical Systems has presented the world's first cartridges developed specifically for the use on high-speed filling lines at the pharmaceutical trade fair Interphex in New York.
SCHOTT has been expanding its manufacturing capacity for small size (1ml to 10 ml) SCHOTT TopPac® syringes in order to address the increasing worldwide demand for prefillable polymer syringes.
SCHOTT has expanding its range of analyses offered due to an increasing demand for laboratory services related to 'extractables and leachables' ('E&L').
SCHOTT is to expand its TopPac polymer syringes range with through launching a 20ml unit that can be used in combination with syringe pumps for infusion therapy.
The future of augmented reality (AR) and mixed reality (MR) is right in front of your eyes. SCHOTT has unveiled the latest addition to SCHOTT RealView™, a product portfolio of high-quality optical glass wafers designed for the realisation of a new era of consumer-grade smart glasses.
International technology group SCHOTT and French engineering firm SINCAD have signed an exclusive cooperation and development agreement aimed at strengthening SCHOTT’s expertise in the field of camera inspection systems.
People undergoing facial plastic surgery expect flawless results. Yet aesthetic injections are not a simple task. That is where SCHOTT TOPPAC® cosmetic syringes come into play.
Complex biological drugs offer hope for some of the hardest-to-treat conditions, from cancer to chronic disease. That promise comes with challenges. For example, biologics requires special packaging that will maintain the drug stability and ensure patient safety.
By breaking ground, speciality glass manufacturer SCHOTT has given the preliminary signal for the erection of a production facility for sterile polymer pharmaceutical primary packaging at its Müllheim site, Germany.
Each drug formulation is unique, as is every patient. Especially high-potency medicines breaking into the market have exacting pharma packaging must guarantee drug stability.
The CEOs of SCHOTT, Stevanato Group, and Gerresheimer have pledged the ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment developed, no matter the patient or region of the world they reside.
The US Pharmacopeia (USP) has proposed a revision to General Chapter Container—Glass, which provides specifications for glass containers used in the pharmaceutical industry. These modifications aim to modernise tests and test methods alongside specifications within the chapter. The underlying goal is to create additional flexibility for packaging and storage requirements. However, many experts in the pharmaceutical industry believe that this is a short-sighted move.
SCHOTT opened the first GMP-compliant pharmaceutical packaging production facility in Russia in May 2011. The plant is located at Zavolzhe near Nizhny Novgorod city in Russia.
SCHOTT Pharma's prefilled syringes (PFS), whether made from glass or advanced polymer, provide a stable, long-term storage solution for drugs while offering a safe and convenient delivery system for both patients and clinicians. With fewer manual steps required compared to conventional packaging, PFS significantly lower the risk of medical errors and infections, prioritising the safety of healthcare professionals and patients alike.
Robust, reliable, and compatible with a wide range of devices, SCHOTT Pharma's cartridge selection ensures precise drug dispensing across diverse medical scenarios.
Made of Type I Borosilicate Glass, SCHOTT Pharma's vials provide exceptional chemical resistance, safeguarding liquid drug formulations during storage. With precise dimensions and superior cosmetic quality, they facilitate an effective fill-and-finish procedure while ensuring container closure integrity.
Manufactured using Type I Borosilicate Glass, SCHOTT Pharma ampoules offer high chemical resistance, accurate dimensions, tight cosmetic control, and drug stability from production to administration. With a focus on quality and safety, our ampoules provide the optimal solution for storing and delivering drugs with confidence.
SCHOTT Pharma offers tailored drug containment and delivery services, providing complete packaging solutions to meet your specific needs. Our comprehensive suite of services includes design, prototyping, and GMP-compliant documentation for primary and related packaging components.
SCHOTT Pharma offers data-driven analytical services that validate the suitability of containment solutions for your specific drug products. Our experts thoroughly assess material compliance, functionality, and drug-container interaction to ensure optimal container selection.
SCHOTT Pharma provides efficient fill-and-finish services, specialising in small-sample filling and closing during the early stages of production. Our expertise extends to conducting analytics to ensure seamless compatibility between packaging, containers, and line equipment.
SCHOTT Pharma provides comprehensive regulatory services to assist drug product and medical device owners in gathering the necessary information for registering containment systems. Our expertise ensures the global availability of information, complying with evolving international regulations, standards, as well as country-specific laws and guidelines.
